The use of primary and secondary doxazosin XL (8 mg) in the treatment of benign prostate hyperplasia: Is there a new approach in the event of alpha-blocker failure?

Abstract Objective: Lower urinary tract symptoms (LUTS), which are related to benign prostate hyperplasia (BPH), are the most commonly encountered diseases in urological practice. In our study, we compared responses to doxazosin mesylate extended release tablets (doxazosin XL) (8 mg) treatment betw...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Muhammet İhsan KARAMAN, Zülfü Sertkaya, Orhan KOCA, Mehmet Akyüz, Mustafa Güneş, Metin İshak Öztürk
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Turkish Association of Urology 2019-07-01
Seri Bilgileri:	Urology Research and Practice
Konular:	Alpha-blocker; benign prostate hyperplasia; doxazosin.
Online Erişim:	http://urologyresearchandpractice.org/index.php/pub/article/view/2764
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!